The Herpes Cure Advocacy team is getting ready for another busy appropriations season and we need your help. Appropriations is the government process of creating a budget and deciding how public funds are spent. Every year – advocates of all kinds hold “appropriations request” meetings to ask for funds. We have a goal of meetingContinue reading “Advocacy Preparations for FY 2023”
Author Archives: Patient Advocate
Moderna Adds Herpes Vaccine Candidate to Pipeline
Moderna is entering the global race for a Herpes vaccine. Moderna is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines. They are best known for recent success with their mRNA-based COVID-19 vaccine. From Moderna website: Moderna’s herpes simplex virus (HSV) vaccine candidate (mRNA-1608) is aContinue reading “Moderna Adds Herpes Vaccine Candidate to Pipeline”
Harvey Friedman provides hope for an HSV Vaccine at the University of Pennsylvania
Researchers, led by Dr. Harvey Friedman, from the Perelman School of Medicine at the University of Pennsylvania are close to clinical trials testing a vaccine protecting against genital herpes. Phase I trials for this HSV vaccine candidate, that will test prevention of genital herpes in humans, are expected to begin in September 2022. In 2019,Continue reading “Harvey Friedman provides hope for an HSV Vaccine at the University of Pennsylvania”
“Moving Beyond a 45 year old antiviral” Article in BioCentury Magazine
Herpes Cure Advocacy win! Our team worked with editors at Biocentury magazine on this article. Enjoy! “After a decades long lull in innovation, a wave of candidates is advancing through the HSV pipeline that could combat drug resistance, suppress viral deactivation, or even clear the virus completely.” Get in Touch
Herpes Cure Pipeline 2.0
Herpes Simplex Virus Cure Pipeline
Hope for Herpes Keratitis Cure in China: Study results expected in 2022
In the global race for a Herpes cure, China is taking the lead. For the first time, transient gene-editing of the herpes simplex virus type 1 (HSV-1) using mRNA-based CRISPR was shown to cure herpes keratitis in mice. Chinese researchers reported in a paper published January 11, 2021 of Nature Biotechnology. In a paper publishedContinue reading “Hope for Herpes Keratitis Cure in China: Study results expected in 2022”
Key Stakeholders for Herpes Patient Advocacy
How long until a herpes cure? When asking this question – ask yourself, what can I do to help? Want to know when the next clinical trial for a herpes cure is? Contact your elected representatives – tell them we need more clinical research for HSV. Contact your elected representatives to ask them to prioritizeContinue reading “Key Stakeholders for Herpes Patient Advocacy”
Herpes Cure Pipeline
Where are we with a Herpes Cure? Our team is tracking HSV research worldwide. (Updated 11/24/21) These are research projects for Herpes Simplex Virus cure, vaccine, or treatment improvements globally with expressed intent of bringing a product to market. View the Herpes research pipeline here. Have a project to add to this list? Contact usContinue reading “Herpes Cure Pipeline”
How to Advocate the FDA for Accurate Herpes Testing
Why do we need advocacy at the FDA? Because any Herpes Simplex Virus prevention strategy in the US is incomplete without an accurate diagnostic test. There is currently NO FDA-approved accurate diagnostic serology test (what we need to diagnose asymptomatic infection) on the market. With a virus that is primarily spread asymptomatically, 85% of newContinue reading “How to Advocate the FDA for Accurate Herpes Testing”
New HSV Advocates: A Starters Guide to Activism
Getting started with Herpes Advocacy Step 1: Get Informed Step 2: Use Your Voice for Change Step 3: Contact stakeholders Step 4: Donate to support advocacy for a cure today Want the latest news on herpes cure, treatment and prevention? Sign up for emails to make sure you never miss a thing.